In-vitro characterization of blood-brain barrier permeability to delta sleep-inducing peptide.
Raeissi. S S; Audus. K L KL
Key Findings
- DSIP crosses the BBB by simple transmembrane diffusion, not by active transport.
- The permeability is comparable to small, water‑soluble compounds and is linear with concentration (non‑saturable).
- DSIP is relatively stable during the experiment, with an apparent half‑life of about 10 hours and minimal breakdown to tryptophan or des‑trp DSIP.
Practical Outcomes
- For biohackers, this means DSIP can reach the brain in its full form, supporting its use for sleep or brain‑related effects without needing complex delivery methods. While the data are from an in‑vitro model, they suggest that peripheral dosing (e.g., subcutaneous or nasal) could be effective, but human studies are still needed to confirm optimal doses and real‑world outcomes.
Summary
The study shows that delta sleep‑inducing peptide (DSIP) can move across the blood‑brain barrier on its own, without needing special carriers or transporters. It does this in a straight‑line (linear) way, similar to small water‑soluble molecules, and the peptide stays mostly intact for many hours.
Abstract
The diffusion of delta sleep-inducing peptide (DSIP) across the blood-brain barrier (BBB) has been investigated with an in-vitro model comprised of primary cultures of brain microvessel endothelial cell (BMEC) monolayers. The BMEC monolayers were mounted in a side-by-side diffusion apparatus and the transendothelial flux of DSIP analysed by HPLC with UV detection at 280 nm. The transendothelial flux of the peptide was linear with time and increasing concentrations of DSIP (non-saturable), but was not altered by reduced temperature. The apparent permeability coefficient for DSIP penetration of BMEC monolayers was in a range similar to water-soluble substances (e.g. fluorescein, fluorescein isothiocyanate dextrans) that penetrate the blood-brain barrier to a limited degree based on molecular weight. DSIP flux across the BMEC monolayers was also found to be bidirectional, insensitive to metabolic inhibitors, and not altered by high concentrations of tryptophan. Little degradation (apparent t1/2 about 10 h) of DSIP to major metabolites, tryptophan (trp) and des-trp DSIP, occurred over the time of the diffusion experiments. The results of these studies support and confirm observations in-vivo indicating that intact DSIP crosses the BBB by simple transmembrane diffusion.
Study Information
pubmed
1989
1989-12-01T00:00:00.000Z
10.1111/j.2042-7158.1989.tb06385.x
34
29